HUNTINGTON BEACH, California, and AMSTERDAM, Jan. 8 /CNW/ - Agendia, a
world leader in molecular cancer diagnostics, today announced the appointment
of Kurt Schmidt, CPA, MBA, as the company's new Chief Financial Officer.
"Kurt is an exceptional addition to our team and an invaluable asset,"
said Bernhard Sixt, Ph.D., President and Chief Executive Officer. "With his
extensive financial management experience in the high tech and healthcare
industries, he will be instrumental in driving Agendia's next phase of
Mr. Schmidt succeeds former Chief Financial Officer, John de Die, who has
been an exemplary guide for Agendia during his tenure. Mr. Schmidt brings more
than 25 years of financial, operational and entrepreneurial management
experience, primarily in the high tech and healthcare industries in the U.S.
and Europe. Most recently, he was a principal at a consulting firm he founded
in 2002, providing high-level interim financial management and M&A services.
Prior to that, Mr. Schmidt served as Operations Director at B2eMarkets, a
supply chain technology company, and Director of Finance & Operations at LA
Gear Europe. Mr. Schmidt started his career at Cardinal Health, Inc. in
"I am delighted to join Agendia during this exciting time and help
prepare the company for our next financing round. I look forward to our first
investor meetings next week during the JP Morgan Healthcare Conference in San
Francisco," commented Kurt Schmidt, Chief Financial Officer.
Agendia is at the forefront of the personalized medicine revolution,
striving to bring more effective, individualized treatments within reach of
patients. Building on a cutting edge genomics platform for tumor gene
expression profiling, the company's tests aim to help physicians more
accurately tailor cancer treatments. The company markets four products, with
several new genomic tests under development. In addition, Agendia collaborates
with pharmaceutical companies to develop highly effective personalized drugs
in the area of oncology. Agendia was awarded the 2008 North American Oncology
Clinical Diagnostics Healthcare Innovation Award by Frost & Sullivan. Agendia
is based in Huntington Beach, California, and in Amsterdam, The Netherlands.
For more information please visit http://www.agendia.com.
For further information:
For further information: MEDIA CONTACTS: Hans Herklots, Head of
Corporate Communications, Agendia, +31-20-462-1557 Office, +31-620-083-509
Mobile, firstname.lastname@example.org; Valerie Delva, Account Executive, Ricochet
Public Relations, (212) 679-3300 x131 Office, (917) 975-3191 Mobile,